Apply Now for Cancer Immunotherapy Winter School
Download the new SITC Clinical Practice Guidelines Mobile App! The first and only immunotherapy-specific clinical practice guidelines app featuring expert panel recommendations. Available for FREE for iOS and Android.
New SITC Clinical Practice Guidelines Published
Targets for Cancer IO: A Deep Dive Series
Celebrate a Decade of Publishing with SITC’s Official Journal
Hear from editors about the state of the field, explore the journal’s major milestones, and read top content.
Get Ready for the SITC Spring Scientific
Date & Location
Saturday, December 3, 2022, 8:00 AM - 4:30 PM, MD Anderson - Main Building, Hickey Auditorium (R11.1400), Houston, TX The Zoom ID and Password will be communicated via email 72 hours before the symposium start time.
We are excited to share that SITC is currently seeking applicants for the NCI Immunotherapy Fellowship . This visiting fellowship begins in July of 2023 and is conducted at the National Cancer Institute's Center for Cancer Research in Bethesda, ...
We are excited to announce the virtual conference "Immunotherapy for Solid Organ Transplant Patients" . Cancer immunotherapy has become a standard therapy for many cancers, but its use in transplant patients is challenging because of safety and efficacy ...
Donate today to support early career scientists who are emerging leaders seeking toadvance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com